Atlas Trials

Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia

Clinical trial NCT00231894 · COMPLETED

Trial details

NCT number
NCT00231894
Sponsor
Nathan Kline Institute for Psychiatric Research
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
DiabetesSchizophreniaInsulin ResistanceCognitive Impairment
Start date
2005-05-01
Primary completion
2010-01-01
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.